Protection against cyclophosphamide-induced alopecia and inhibition of mammary tumor growth by topical 1,25-dihydroxyvitamin D3 in mice

International Journal of Cancer

Volumn 75, Issue 2, 1998, Pages 303-309

  Chen, Guan ^a   Baechle, Alec ^a   Nevins, Thomas D ^b   Oh, Susan ^a   Harmon, Charles ^b   Stacey, Dennis W ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Preclinical Dermatology Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CYCLOPHOSPHAMIDE;

ALOPECIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER INHIBITION; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; FEMALE; HAIR GROWTH; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ALOPECIA; ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; CALCITRIOL; CELL DIVISION; CYCLOPHOSPHAMIDE; FEMALE; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C;

EID: 0032545725     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980119)75:2<303::AID-IJC21>3.0.CO;2-C     Document Type: Article

References (25)

1. ARMBRECHT, H.J. and BOLTZ, M.A., Expression of 25-hydroxyvitamin D 24-hydroxylase cytochrome P450 in kidney and intestine. Effect of 1,25-dihydroxyvitamin D and age. FEBS Lett., 292, 17-20 (1991).
2. BECK, W.T., DEDMON, M.L. and OUELLETTE, M.A., Biochemical basis for impaired drug metabolism in tumor-bearing rats. Biochem. Pharmacol., 31, 1535-1543 (1982).
3. CHEN, G., TEICHER, B.A and FREI III, E., Biochemical characterization of in vivo alkylating agent resistance of a murine EMT-6 mammary carcinoma. Implication for systemic involvement in the resistance phenotype. Cancer Biochem. Biophys., (1997) (In press).
4. COLSTON, K.W., BERGER, U. and COOMBES, R.C., Possible role for vitamin D in controlling breast cancer cell proliferation. Lancet, i, 188-191 (1989).
5. 3 in NRP-152 rat prostatic epithelia cells. J. cell. Physiol., 166, 231-239 (1996).
6. DRY, F.W., The coat of the mouse (Mus musculus). J. Genet., 16, 287-340 (1926).
7. 3 induces sphingomyelin hydrolysis in HaCat cells via tumor necrosis factor α. J. biol. Chem., 272, 8997-9001 (1997).
8. 3 and skin: a unique application for the treatment of psoriasis. Proc. Soc. exp. Biol. Med., 191, 246-257 (1989).
9. 3 receptor concentration in mouse skin and intestine. J. invest. Dermatol., 84, 461-464 (1985).
10. HUSSEIN, A.M., JIMENEZ, J.J., MCCALL, C.A. and YUNIS, A.A., Protection from chemotherapy-induced alopecia in a rat model. Science, 249, 1564-1566 (1990).
11. 3. Cancer Res., 52, 5123-5125 (1992).
12. KAWABE, T., REA, T.J., FLENNIKEN, A.M., WILLIAMS, B.R.G., GROPPI, V.E. and BUHL, A.E.E., Localization of TIMP in cycling mouse hair. Development. 111, 877-879 (1991).
13. 3 analogues in breast cancer cells. Cancer Res., 56, 2789-2794 (1996).
14. LOWE, K.E., MAIYAR, A.C. and NORMAN, A.W., Vitamin D-mediated gene expression. Crit. Rev. Eukaryotic Gene Express., 2, 65-109 (1992).
15. OH, H. and SMART, R.C., An estrogen receptor pathway regulates the telogen-anagen hair follicle transition and influences epidermal cell proliferation. Proc. nat. Acad. (Wash.), 93, 12525-12530 (1986).
16. OKUDA, K.I., USUI, E. and OHYAMA, Y. Recent progress in enzymology and molecular biology of enzymes involved in vitamin D metabolism. J. Lipid Res., 36, 1641-1652 (1995).
17. ORNOY, A., SUISSA, M., YAFFE, P., BOYAN, B.C. and SCHWARTS, Z., Gender-related effects of vitamin D metabolites on cartilage and bone. Bone Mineral, 27, 235-247 (1994).
18. PAUS, R.B., HANDJISKI, S., EICHMULLER, S. and CZARNETZKI, B., Chemotherapy-induced alopecia in mice: induction by cyclophosphamide. inhibition by cyclosporine A. and modulation by dexamethasone. Amer. J. Pathol., 144, 719-734 (1994).
19. PAUS, R.B., SCHILLII, M.B., HANDJISKI, B., MENRAD, A., HENZ, B.M. and PLONKA, P., Topical calcitriol enhances normal hair regrowth but does not prevent chemotherapy-induced alopecia in mice. Cancer Res., 56, 4438-4443 (1996).
20. POWIS, G. and KOOISTRA, K.L., Doxorubicin-induced hair loss in the angora rabbit: a study of treatments to protect against the hair loss. Cancer Chemother. Pharmacol., 20, 291-296 (1987).
21. REICHEL, H., KOEFFLER, H. and NORMAN, A.W., The role of the vitamin D endocrine system in health and disease. N. Engl. J. Med., 316, 980-991 (1989).
22. ROCKWELL, S.C., KALLMAN, R.F. and FAJARDO, L.F., Characteristic of a serially transplanted mouse mammary tumor and its tissue culture-adapted derivative. J. nat. Cancer Inst., 49, 735-749 (1972).
23. 3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions. J. invest. Dermatol., 86, 709-714 (1986).
24. STUDZINSKI, G., MCLANE, J.A. and USKOKOVIC, M.R., Signaling pathways for vitamin D-induced differentiation: implication for therapy of proliferative and neoplastic diseases. Crit. Rev. Eukaryotic Gene Express., 3, 279-312 (1993).
25. WAXMAN, D.J., Interactions of hepatic cytochromes P450 with steroid hormones. Regioselectivity and stereospecificity of steroid hydroxylation and hormonal regulation of rat P450 enzyme expression. Biochem. Pharmacol., 37, 71-84 (1988).